DrugPatentWatch Database Preview
Profile for Canada Patent: 2505801
US Patent Family Members and Approved Drugs for Canada Patent: 2505801
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Aug 1, 2021 | Kastle Theraps Llc | KYNAMRO | mipomersen sodium |
➤ Sign Up | Jan 29, 2027 | Kastle Theraps Llc | KYNAMRO | mipomersen sodium |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |